Nov 9 (Reuters) – Swiss drug developer Windward Bio Group AG is targeting a valuation of up to $1 billion in its US initial public offering, as a strong run for the biotech IPO market extends into
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Comedian Russell Brand found guilty by UK court of rape and sexual assaults
(The Nov 5 story was republished in error. The inconvenience caused is regretted.) By Sam…
Impossible Metals says it has successfully tested AI seabed mining robot
Nov 9 (Reuters) - Deep-sea mining firm Impossible Metals said on Monday it has successfully…
Poland's Linette ends two-year wait for tour title after winning Chennai Open
VIDEO SHOWS: HIGHLIGHTS OF THE WTA CHENNAI OPEN FINAL SHOTLIST AND SCRIPT TO FOLLOW SHOWS:…
